Introduction
============

Stem cells have inherent chondrogenic potential and serve an important role in healing articular cartilage defects ([@b1-etm-0-0-7499]). Bone marrow stem cells, which may be obtained by stimulation techniques and by subchondral drilling, have been demonstrated to improve the cartilage healing process; however, these methods result in a fibrocartilage-like tissue that deteriorates over time ([@b2-etm-0-0-7499]). Other techniques, including autologous chondrocyte implantation, have been used to improve the quality of the repaired tissue to make it more similar to hyaline-like cartilage tissue ([@b3-etm-0-0-7499]). However, long-term follow-up has identified similar results in terms of clinical outcome and histological scoring between microfracture and autologous chondrocyte implantation techniques ([@b3-etm-0-0-7499]).

During articular cartilage repair, paracrine factors may influence the inflammatory process involved in fibrocartilage tissue formation. Hyaluronic acid, stem cells and growth factors (GFs) have provided important results with regards to the suppression of inflammatory process ([@b4-etm-0-0-7499]) and may act synergistically in cartilage regeneration ([@b5-etm-0-0-7499],[@b6-etm-0-0-7499]). Notably, experimental cartilage repair studies have demonstrated promising results when combining subchondral drilling with postoperative intraarticular injections of autologous bone marrow aspirate and hyaluronic acid ([@b4-etm-0-0-7499]). Synovitis and synovial fluid alterations as a response to the inflammatory process has also been indicated to influence the articular environment and may affect cartilage repair ([@b7-etm-0-0-7499]).

The use of platelet-rich plasma (PRP), a rich source of autologous GFs, may be considered a useful approach for cartilage repair ([@b8-etm-0-0-7499]). Platelets serve a crucial role in the normal healing response of connective tissues through the local secretion of GFs and recruitment of reparative cells ([@b9-etm-0-0-7499]). PRP is a potential scaffold option for tissue regeneration: It has been suggested for the stimulation of chondrogenic differentiation and proliferation of stem cells, chondrocyte proliferation and cartilage formation ([@b10-etm-0-0-7499]--[@b12-etm-0-0-7499]).

The type of stem cell may influence the quality of tissue repair ([@b13-etm-0-0-7499]). Human dental pulp stem cell (hDPSC) subpopulations have been demonstrated to have substantial angiogenic, neurogenic and regenerative potential when compared with other stem cell sources ([@b14-etm-0-0-7499],[@b15-etm-0-0-7499]).

The purpose of the present study was to evaluate the potential of hDPSCs in a PRP scaffold to regenerate full-thickness articular cartilage defects in rabbits. It was hypothesized that hDPSCs in a PRP scaffold may improve articular cartilage repair.

Materials and methods
=====================

A total of 32 New Zealand male rabbits (obtained from the Department of coordinating production and maintenance of rabbits, Serviço de Biotério, Prefeitura do Campus da USP (Universidade de São Paulo) (aged 4--6 months, weighing \~3 kg) were used in the present study. Rabbits were maintained in standardized individual cages, at a temperature of \~21°C, a humidity of 45--55% and a 12--14/24 h light/dark cycle. Additionally, rabbits and received *ad libitum* access to ground solid rations (Anderson and Clayton S.A.) and water. A total of 30 rabbits comprised the experimental group (60 knees), and 2 rabbits were used to obtain PRP. The study protocol of the present experiment was reviewed and approved by the Ethics Committee at Faculdade de Medicina de Marília, São Paulo, Brazil (EC No. 641/12).

### hDPSC isolation and culture

Dental pulp cells were extracted from one tooth that had been previously selected for exodontia from a healthy 10 year old female patient at a private dental clinic, on June 2006 ([@b16-etm-0-0-7499]). Cells were extracted using endodontic files under a biosafety hood and placed in culture flasks with Dulbecco\'s modified Eagle\'s medium (DMEM) supplemented with 10% fetal bovine serum (Cultilab, Campinas, SP, Brazil) and 50 mg/ml gentamicin at 37°C in an atmosphere containing 5% CO~2~ as previously described by Jesus *et al* (2011) ([@b16-etm-0-0-7499]). The growth medium was changed every 3 days. Once cells reached confluence, the cells were dissociated with 0.25% trypsin (Gibco, Thermo Fisher Scientific, Inc., Waltham, MA, USA). Some of the cells were separated for cryopreservation. A maximum of 10^6^−10^7^ cells per tube were observed and a final volume of 1 ml was then achieved through the addition of DMEM medium supplemented with 10% fetal bovine serum 900 µl (cat. no. 12657029; Gibco; Thermo Fisher Scientific, Inc.) and dimethyl sulfoxide (100 µl; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany). Cryopreservation tubes were then subjected to cryostat reduction for 24 h at −80°C and then stored in liquid nitrogen (−196°C). The procedures were performed in the Center for Biotechnology and Cell Therapy, Monte Tabor Hospital São Rafael (Salvador, Brazil).

### Flow cytometry

Adherent cells in the sixth passage (P6) and cultures with 60% confluence were selected for the detection of surface and intracellular antigens. Antibody staining was performed as follows: Cell aliquot (100 µl) containing at least 10^6^ nucleated cells were placed into each tube and incubated for 30 min at room temperature with 0.5% PBS/BSA (Sigma-Aldrich, Merck KGaA) for blocking. Samples were then stained with conjugated antibodies (all 1:100) for 15 min at room temperature in the dark. Subsequently cells were resuspended twice in 4 ml PBS (Sigma-Aldrich) and centrifuged at a speed of 540 × g for 5 min at 4°C. Following centrifugation, the supernatant was discarded and the cell pellet was ressuspended in 500 µl PBS + 0.5% BSA and stored at 4°C. The antibodies used are listed in [Table I](#tI-etm-0-0-7499){ref-type="table"}. Data acquisition and analysis were performed using a FACS Calibur flow cytometer (BD Biosciences) and the Cell Quest program version 5.2 (BD Biosciences). At least 50,000 events were collected and analyzed. Unlabeled antibodies cells were used as controls.

### Immunofluorescence

hDPSCs from P6 were used for phenotypic characterization using immunofluorescence. Cells were trypsinized and seeded in 24-well plates containing 13 mm glass coverslips (Waldemar Knittel Glasbearbeitungs GmbH, Braunschweig, Germany). Following adherence for 24 h, the culture medium was removed and two washes with PBS were performed. Cells were fixed with 4% paraformaldehyde for 20 min at room temperature. Two wells were then washed with PBS for 3 min. For the staining of nuclear antigens, cells were permeabilized with 0.1% Triton X-100 for 10 min at room temperature. Blocking was then performed with 5% PBS/BSA (Sigma-Aldrich) for 30 min at room temperature and incubated overnight at 4°C with the following primary antibodies: Anti-CD44 (1:100; cat. no. 08-0184; Zymed; Thermo Fisher Scientific, Inc.), anti-cluster of differentiation (CD)45 (1:100; cat. no. AHS4552; BioSource; Thermo Fisher Scientific, Inc.) anti-CD90 (1:100; cat. no. 550402; BD Bioscences), anti-CD105 (1:100; cat. no. 555690; BD Bioscences) anti-CD73 (1:100; cat. no. 550738; BD Bioscences), anti-CD117 (1:100; cat. no. ab16832; Abcam, Cambridge, MA, USA), anti-CD133 (1:25; cat. no. ab19898; Abcam) anti-myosin (1:100; cat. no. M7523; Sigma-Aldrich), anti-collagen type I (1:50; cat. no. sc-8788; Santa Cruz Biotechnology Inc., Dallas, TX, USA), anti-glial fibrillary acidic protein (1:50; cat. no. Z0334; Dako; Agilent Technologies, Inc., Santa Clara, CA, USA) and anti-myelin (1:100; cat. no. 18-0038; Zymed; Thermo Fisher Scientific, Inc.). Slides were visualized and images were captured using a confocal microscope (magnification, ×400; FluoView 1000; Olympus, Tokyo, Japan).

### Cytogenetic analysis

hDPSCs were prepared for cytogenetic analysis as previously described and analyzed using the G-banding technique ([@b17-etm-0-0-7499]). Slides were observed using an optical microscope (magnification, ×1,000) and \~20 metaphases of each sample were analyzed for the presence of numerical and/or structural cytogenetic abnormalities according to the International System for Chromosome Nomenclature ([@b18-etm-0-0-7499]). Images were captured using Image-Pro Plus software, version 7.0 (Media Cybernetics, Inc., Rockville, MD, USA). All cells obtained from P5 and P6 demonstrated a normal female karyotype (karyotype: 46, XX) ([@b18-etm-0-0-7499]).

### Obtaining and preparing PRP

PRP was obtained from 2 adult New Zealand rabbits (age, 4--6 months; weight, \~3--5 kg). The animals underwent general anesthesia by administering an intramuscular injection of 10 mg/kg xylazine hydrochloride (VET Brands International, Inc., Miramar, FL, USA) followed by an intramuscular injection of 30 mg/kg ketamine hydrochloride (VET Brands International, Inc.). Animals were deemed to be anesthetized when the following parameters were observed: The presence of muscular paralysis, the absence of reflexes and pain. These animals were not used in the experimental groups and following blood extraction, rabbits were euthanized with an overdose (20 mg/kg) of Propofol (Cristália Produtos Químicos Farmacêuticos Ltda., Itapira, São Paulo, Brazil) administered by intravenous injection. Death was confirmed by the lack of a heartbeat, lack of respiration, lack of corneal reflex and the presence of rigor mortis. Cardiac puncture and blood extraction were performed with a 10-ml disposable syringe containing 1 ml 3.2% sodium citrate and a 30×8 mm needle. A total of 9 ml of arterial blood was collected in each syringe and a total of 18 ml of arterial blood was obtained to prepare the PRP. Following collection, the blood was homogenized and transferred to collection tubes (BD Vacutainer; BD Biosciences).

The collected tubes containing the blood were subjected to two centrifugation steps, the first of which was performed at 200 × g for 10 min at 24°C to separate the blood cells. The supernatant plasma and buffy coat were transferred to a new sterile tube and underwent a second centrifugation step at 400 × g for 10 min at 24°C. The collected plasma underwent a further centrifugation step at 400 × g for 10 min at 24°C to concentrate the platelets to \~1,000,000 per µl. Subsequently, the supernatant was removed to achieve a final volume of 1,600 µl of PRP for every 9 ml of arterial blood. PRP was separated into two 800-µl aliquots, placed into sterile cryotubes and stored in a freezer at −80°C for subsequent experiments. A sample was obtained for platelet counting, which was performed manually using a hemocytometer (Hausser Scientific, Horsham, PA, USA) and was used as a control in order to ensure the minimum concentration of platelets was 1,000,000 per µl.

Prior to the surgical procedure, *hDPSCs* were grown in α-MEM medium (Gibco; Thermo Fisher Scientific, Inc.) supplemented with 10% fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc.) at 37°C and 5% CO~2~ until 80% confluent cultures were obtained. Cells were then detached from the growth surface with 0.25% trypsin (Gibco; Thermo Fisher Scientific, Inc.) and immediately transferred to a tube containing α-MEM medium (supplemented with 10% fetal bovine serum. Samples were centrifuged twice at 175 × g for 10 min at room temperature and the supernatant was removed. Then, PRP was thawed completely, homogenized, divided into 200-µl samples and added to 2,8×10^6^ hDPSCs (P5 and P6). The PRP thawing procedure and preparation of the cells was synchronized with the start of surgery and maintained for approximately 10--15 min at room temperature (23--25°C).

### Cell viability

*hDPSCs* were suspended in PRP and stained with blue tripan reagent (1.6%; v/v; Sigma-Aldrich; Merck KGaA; cat. no. T6146) for 1 min at room temperature and cell viability of \~80% was confirmed by the manual counting technique using a hemocytometer (Hausser Scientific, Horsham, PA, USA).

### Surgical procedure and experimental groups

Rabbits received general anesthesia with of 10 mg/kg intramuscular xylazine hydrochloride (Vet Brands International, Inc., Miramar, FL, USA) followed by an intramuscular injection of 30 mg/kg ketamine hydrochloride (Vet Brands International, Inc., Miramar, FL, USA). Each rabbit\'s right and left knees were shaved and the overlying fur was removed. Antisepsis was performed with 10% polyvinylpyrrolidone topical solution (RioquímicaIndústria Farmaceutica, São José do Rio Preto, Brazil). An incision was made on the anteromedial section of the knees and the patella was dislocated laterally to expose the patellar groove of the femur. Full-thickness cartilage defects (5×5 mm) down to the subchondral bone were created in the patellar groove using an odontologycal surgical motor for dental implants (Gnatus Produtos Médicos e Odontológicos Ltda EPP, São Paulo, Brazil) quipped with a 5-mm diameter trephine drill and constant irrigation with 0.9% saline solution ([Fig. 1A](#f1-etm-0-0-7499){ref-type="fig"}).

Rabbits were allocated into three experimental groups: Control (CTL), PRP and PRP with stem cells (PRP+SC) groups. Both knees of each rabbit were operated on and the 5 mm critical defects were created. In the CTL group, the defects received no further treatment. In the PRP group, the defects in both knees were filled with 100 µl of PRP gel activated with 10% calcium gluconate (Fresenius Kabi Brasil Ltda, Barueri, São Paulo, Brazil). In the PRP+SC group, the defects in both knees were filled with 1.4×10^6^ hDPSCs resuspended in 100 µl of PRP gel activated with 10% calcium gluconate ([Fig. 1B and C](#f1-etm-0-0-7499){ref-type="fig"}). The patella was carefully repositioned and the capsule and skin were closed with 4-0 nylon sutures in all of the operated knees. In each group, 5 rabbits were euthanized at 6 weeks and 5 were euthanized at 12 weeks post-surgery.

### Macroscopic evaluation

Macroscopic evaluation of cartilage repair was performed at 6 and 12 weeks by two independent observers. The International Cartilage Repair Society (ICRS) evaluation grading system was used as indicated in [Table II](#tII-etm-0-0-7499){ref-type="table"} ([@b19-etm-0-0-7499],[@b20-etm-0-0-7499]).

### Histological cartilage evaluation

The distal femur was removed, placed in 10% formalin, decalcified in EDTA, embedded in paraffin and sagittally cut into 5-µm thick sections. Sections were stained with hematoxylin and eosin (H&E) and a Masson-Goldner kit was used for histomorphometric tissue analysis. The microscopic evaluations were performed by two different researchers and scored according to a modified version of the grading system developed by O\'Driscoll ([@b21-etm-0-0-7499],[@b22-etm-0-0-7499]), as indicated in [Table III](#tIII-etm-0-0-7499){ref-type="table"}. The investigators who performed the evaluations were blind to the treatment.

### Histology of the synovial membrane

Synovial membrane samples were collected from the lateral parapatellar region for analysis when the animals were euthanized at 6 and 12 weeks. The synovial membrane was placed in 10% formalin at room temperature for 24 h and subsequently embedded in paraffin, sectioned at a thickness of 5 µm and stained with H&E at room temperature for 15 min. The specimens were evaluated by two independent observers using a conventional photonic microscope at a magnification of ×40 (Olympus BX41; Olympus Corporation, Tokyo, Japan). The sections were each allocated a Krenn\'s synovitis score ([@b23-etm-0-0-7499]), the details of which are indicated in [Table IV](#tIV-etm-0-0-7499){ref-type="table"}. A slice of each sample was examined according to the scores and the mean and median scores were calculated for each group.

### Statistical analysis

The mean values, standard deviations and medians were obtained for each group. The Kruskall-Wallis test was used to determine statistical significance in the differences between the three groups\' Krenn synovitis score, the modified O\'Driscoll score and the ICRS score, respectively. In cases where this test exhibited significant differences among the three groups, the Kruskall Wallis post-hoc multiple comparisons of mean ranks of all pairs of groups, with Bonferroni\'s correction was applied. P\<0.05 was used to indicate a statistically significant difference. The software used for statistical analysis was performed using the Statistica 8.0. software \[STATISTICA (data analysis software system) version 8.0. [www.statsoft.com](www.statsoft.com); TIBCO software, Inc., Palo Alto, CA, USA\].

Results
=======

### Macroscopic analysis at 6 weeks

The CTL group exhibited irregular tissue repair with several fissures, and in some knees the defect was not completely filled. The PRP group revealed irregularly repaired cartilage with several fissures that were thinner compared with the surrounding cartilage. Furthermore, in some specimens the center of the defect still had the subchondral bone exposed. Notably, the PRP+SC group demonstrated more regular tissue repair that was level with the surrounding cartilage and exhibited small fissures. At 6 weeks, the PRP+SC group grades were significantly improved compared with those of the PRP group (P=0.003; [Table V](#tV-etm-0-0-7499){ref-type="table"}). However, the PRP group exhibited a lower score compared with the CTL group, though this difference was not statistically significant (P=0.31).

### Macroscopic analysis at 12 weeks

Tissue repair in the CTL group did not significantly improve at 12 weeks post-surgery and the group exhibited irregular tissue repair with several fissures and partial border integration. The PRP group was notably improved and tissue repair was more level with the surrounding cartilage, with small fissures and partial border integration. Furthermore, the PRP+SC group revealed smoother surface cartilage repair that was level with the surrounding cartilage and almost complete border integration. At 12 weeks, the macroscopic grades of the PRP+SC group were significantly improved compared with those of the CTL and the PRP group (P=0.001 and P=0.049, respectively; [Table V](#tV-etm-0-0-7499){ref-type="table"}).

Histological cartilage evaluation
---------------------------------

### CTL group

A total of 6 weeks following the surgical procedure, the defects were filled with a thick mixture of hyaline-like and fibrocartilaginous tissue in addition to viable cells. Some irregularities were indicated on the surface. No cellular or tissue organization was noted and there was no distinction between the cartilaginous, calcified cartilage and subchondral bone zones. The zone corresponding to the calcified zone sometimes exhibited continuity with fibrous connective tissue; in other cases, this zone exhibited continuity with the mineralized bone remodeling matrix. Furthermore, highly vascularized tissue was above the bone marrow region, which was composed of large blood vessels and occasional sites of clustered inflammatory mononuclear cell infiltrate. In the majority of cases, one of the edges of the defects was not continuous with the adjacent normal cartilage and was occasionally interspersed with fibrous connective tissue or gaps revealing bare bone surface ([Fig. 2](#f2-etm-0-0-7499){ref-type="fig"}).

At 12 weeks, the defects were primarily filled with fibrocartilage. Cellular distribution was disorganized, cells were predominantly viable and the surface exhibited irregularities. The majority of the samples exhibited a gap in the central region of the defect. Furthermore, the subchondral bone in the more central portions were replaced by highly vascularized connective tissue. In some samples, there was abnormal mineralization of cartilage in the focal points outside of the calcification zone. Partial continuity of the repaired cartilage with the normal adjacent cartilage was observed.

### PRP group

A total of 6 weeks following the surgical procedure, the defects were filled with a mixture of hyaline-like and fibrocartilaginous tissue, in addition to disorganized viable cells. The surface exhibited fibrillation and irregularities. Notably, improved subchondral bone remodeling was observed. There was also partial continuity with the adjacent normal cartilage ([Fig. 2](#f2-etm-0-0-7499){ref-type="fig"}).

At 12 weeks, the defects were filled mostly with hyaline-like cartilage and the surface exhibited fibrillation and irregularities. On the border of the defect, some areas demonstrated features similar to those of normal cartilage organization with regular bone trabeculae, whereas in the center of the defect, thicker cartilage had begun to exhibit columnar cell organization with increased subchondral bone remodeling. In some samples, the subchondral bone was replaced by fibrous connective tissue. There was partial continuity with the adjacent normal cartilage ([Fig. 2](#f2-etm-0-0-7499){ref-type="fig"}).

### PRP+SC group

At 6 weeks, the defects were predominantly filled with hyaline-like cartilage. Cellular distribution was disorganized, cells were viable and the surface was moderately smooth. In the subchondral region, half of the samples exhibited fibrous connective tissue with areas of granulation without continuity and with the bone corresponding to the central region of the defect. Islands of cartilage were observed amid the medullary bone in the region corresponding to the defect. In some cases, granulation tissue or foci of calcification were identified to be interposed in the cartilaginous layer. Notably, there was partial continuity with the adjacent normal cartilage ([Fig. 2](#f2-etm-0-0-7499){ref-type="fig"}).

At 12 weeks, the defects were predominantly filled with hyaline-like cartilage and early signs of columnar cell organization were apparent. The surface was smooth and lamina splendens were present. Bone trabeculae in the subchondral region were regular and in the process of remodeling. Furthermore, lateral integration with the adjacent normal cartilage partially occurred in the majority of the defects ([Fig. 2](#f2-etm-0-0-7499){ref-type="fig"}).

As indicated in [Table VI](#tVI-etm-0-0-7499){ref-type="table"}, histological scoring assessment at 6 weeks demonstrated that the PRP+SC group had a significantly higher mean score compared with the CTL group regarding the histological assessment of surface architecture and lateral integration of implanted material (P=0.0009 and P=0.0069, respectively). Regarding histological assessment of surface architecture, the PRP group exhibited no significant differences with the CTL group. Furthermore, the PRP+SC group exhibited a significantly higher score compared with the PRP group regarding the histological assessment of surface architecture and lateral integration of implanted material (P=0.0148 and P=0.0059, respectively).

As indicated in [Table VII](#tVII-etm-0-0-7499){ref-type="table"}, at 12 weeks the PRP+SC group was indicated to have a significantly higher mean histological evaluation score compared with the CTL group for the following variables: Tissue morphology, matrix staining, chondrocyte clustering in implant, histological assessment of surface architecture, subchondral bone formation and total score (P=0.0037, P=0.0172, P=0.0323, P=0.0006, P=0.0465 and P=0.0021, respectively; [Table VII](#tVII-etm-0-0-7499){ref-type="table"}). Additionally, the PRP group scores were higher compared with those of the CTL group in the cases of tissue morphology, matrix staining, intactness of calcified layer and tidemark formation, histological assessment of surface architecture, subchondral bone formation and total score (P=0.0363, P=0.0024, P=0.0132, P=0.0209, P=0.0323 and P=0.0076, respectively; [Table VII](#tVII-etm-0-0-7499){ref-type="table"}). There were no significant differences between the PRP+SC group and the PRP group.

### Synovial membrane microscopic morphological analysis using Krenn\'s synovitis scoring

At 6 weeks, the synovial membranes of all three groups exhibited loose connective tissue with slightly increased cellularity and were permeated by discrete perivascular lymphocytic inflammatory infiltrate ([Fig. 3](#f3-etm-0-0-7499){ref-type="fig"}). Furthermore, the layer of synovial lining cells was enlarged in the CTL group and consisted of two to three smaller cell layers. Conversely, the PRP and PRP+SC groups typically exhibited a single layer of synovial lining cells. As indicated in [Table VIII](#tVIII-etm-0-0-7499){ref-type="table"}, the enlargement of the synovial lining cell layer was significantly increased in the CTL group when compared with the PRP group (P=0.037) and had a tendency to be increased when compared with the PRP+SC group. In addition, a low degree of synovitis was identified in all three groups at 6 weeks ([Table VIII](#tVIII-etm-0-0-7499){ref-type="table"}).

At 12 weeks, the three groups exhibited normal cellularity and no evident inflammation. The layer of synovial lining in the CTL group continued to be comprised of two to three smaller cell layers and the PRP and PRP+SC groups exhibited a normal single layer; however, the difference between the synovitis evaluation scoring in these groups was not statistically significant. Notably, no synovitis was indicated in any of the three groups at 12 weeks ([Fig. 3](#f3-etm-0-0-7499){ref-type="fig"}; [Table VIII](#tVIII-etm-0-0-7499){ref-type="table"}).

Discussion
==========

A primary advantage of mesenchymal stem cells (MSCs) is their capacity to differentiate into osteocytes and chondrocytes, and their ability to regenerate cartilage and the underlying subchondral bone essential for adequate healthy cartilage support ([@b24-etm-0-0-7499]). The use of stem cells in articular cartilage repair is promising, and has been demonstrated to enhance repair; however, its experimental application through intraarticular MSC injections may result in fibrocartilaginous tissue formation ([@b25-etm-0-0-7499]). This outcome reflects the fact that other factors are involved in adequate cell differentiation and tissue repair ([@b24-etm-0-0-7499]--[@b28-etm-0-0-7499]).

Synovial fluid serves a key role in osteoarthritis by allowing for different tissue communication inside the joint in multidirectional pathways ([@b29-etm-0-0-7499],[@b30-etm-0-0-7499]). In cases of osteoarthritis, the synovial fluid is a predominant source of extrinsic signaling factors and proinflammatory cytokines, and there is an increased number of MSCs present ([@b31-etm-0-0-7499]). This increase in MSCs in the synovial fluid and the cases of synovitis with infiltration of inflammatory cells in the synovium maybe interpreted as responses to inflammation and tissue injury. It has been reported that signaling molecules contribute to cartilage repair involving the synovial fluid and the calcified cartilage of the subchondral bone, which allows for these locations to interact as functional units ([@b32-etm-0-0-7499]).

In the present study, synovial analysis revealed low-grade synovitis at 6 weeks in all groups and decreased synovitis at 12 weeks. Although the degree of synovitis was similar between the groups, the CTL group exhibited pronounced enlargement of the synovial lining layer, which persisted at 12 weeks. This finding validated the interaction and signaling of tissue repair with the synovium after the creation of the defect and raises the question whether the synovium and synovial fluid should also be targeted to improve cartilage tissue repair. A previous experimental study on rabbits indicated multiple joint injections of PRP to be beneficial in reducing synovitis and inflammatory factors and in restoring damaged tissue ([@b7-etm-0-0-7499]). In addition, PRP has been demonstrated to stimulate cell proliferation and superficial zone protein secretion by articular cartilage and synovium in the human knee joint ([@b33-etm-0-0-7499]). The mechanisms of action in PRP therapy are complex, multifaceted and remain to be fully elucidated. However, in osteoarthritis, PRP has been suggested to exhibit pro-anabolic or anti-catabolic mechanisms and to provide pain relief ([@b29-etm-0-0-7499]). In the present study, although the difference was not statistically significant, the PRP and PRP+SC groups exhibited reduced synovitis at 6 and 12 weeks compared with the respective CTL groups. However, further study is warranted to determine whether synovitis maybe attenuated by PRP or stem cells, and thus influence cartilage repair.

MSCs differ in their chondrogenic potential. When the synovial fluid, synovium, bone marrow, adipose tissue and muscle MSCs were compared, those of the synovial fluid, synovium and bone marrow exhibited improved chondrogenic potential ([@b13-etm-0-0-7499],[@b34-etm-0-0-7499],[@b35-etm-0-0-7499]). The present study examined hDPSCs because hDPSC subpopulations have been demonstrated to have higher angiogenic, neurogenic and regenerative potential compared with bone marrow stem cells or adipose stem cells ([@b14-etm-0-0-7499]). The chondrogenic potential of hDPSCs has not been compared to that of other MSCs; however several *in vitro* and *in vivo* studies have suggested hDPSCs as a promising tool for cartilage repair ([@b15-etm-0-0-7499],[@b36-etm-0-0-7499],[@b37-etm-0-0-7499]), which was corroborated by the present study.

A review of *in vitro* studies has indicated a positive interaction between PRP and MSCs with regards to stimulation of stem cell proliferation, the lack of interference with lineage differentiation, preservation of multipotency and the immune-privileged characteristics of the MSCs and the delay of the development/emergence of the senescent phenotype ([@b38-etm-0-0-7499]). In the case of articular cartilage repair, a review has demonstrated that PRP may stimulate chondrogenic differentiation *in vitro* and enhance cartilage repair in animal studies ([@b39-etm-0-0-7499]). Notably, PRP has diverse compositions, concentrations and activation methods, which produce conflicting results on its effects on cartilage repair ([@b40-etm-0-0-7499],[@b41-etm-0-0-7499]). Carneiro *et al* ([@b42-etm-0-0-7499]) reported the use of autologous PRP gel with the presence of leukocytes concentrated two to three times in a full-thickness cartilage defect in an ovine model. The study indicated improved results after 12 weeks, though the repair did not consist of hyaline cartilage. Serra *et al* ([@b43-etm-0-0-7499]) reported the use of multiple injections of autologous PRP in a full-thickness defect in a rabbit model and observed no differences in repair relative to controls after 19 weeks. Additionally, Milano *et al* ([@b22-etm-0-0-7499],[@b44-etm-0-0-7499]) reported a positive effect of PRP on cartilage repair after microfractures and identified the effect to be more pronounced when PRP was mixed with fibrin glue and used as a gel in comparison with a liquid intraarticular injection; however, hyaline cartilage formation was not observed ([@b22-etm-0-0-7499]). The PRP gel scaffold used in the present study was homologous and contained leukocytes, which may influence the hDPSCs and autologous bone marrow cells present in the defect ([@b45-etm-0-0-7499]).

In the present study, the use of PRP gel containing hDPSCs at the defect site contributed to improved subchondral bone formation, with repaired tissue consisting primarily of hyaline-like cartilage. In addition, a smooth articular cartilage surface was indicated. By contrast, the CTL group exhibited a more irregular and fibrillated articular cartilage surface and the repaired tissue consisted mostly of fibrocartilage. Notably, the full-thickness cartilage defect created in the present study allowed exposure of the subchondral bone. As a result, a more pronounced migration of bone marrow cells can occur, which promotes interaction with the PRP and the hDPSCs ([@b46-etm-0-0-7499]). This type of interaction may be useful in a surgical intervention for cartilage repair but requires further exploration.

The present results indicated that, in the PRP and PRP+SC groups the formation of a homogeneous calcified cartilage and tidemark was improved compared with the CTL group, particularly on the border of the defect. Furthermore, the quality of the adjacent repaired cartilage was also improved. In all three groups, the center of the defect still had signs of subchondral bone remodeling in which vascularized connective tissue was present, particularly in the CTL group. The findings of the present study suggest that adequate subchondral bone formation and remodeling seem to be fundamental for restoring and obtaining high quality repaired cartilage. Notably, a 12-week follow-up period is short and differences in subchondral bone and any gaps in healed cartilage may likely be more pronounced at 24 weeks ([@b47-etm-0-0-7499]).

The lamina splendens consists of collagen fibrils that run parallel to the surface of the joint ([@b48-etm-0-0-7499]). It is responsible for maintaining the mechanical response of the articular cartilage to load absorption and is the first component to degrade in osteoarthritis ([@b49-etm-0-0-7499]). If the surface zone layer and adequate superficial zone protein (lubricin) are not reestablished, their loss may lead to the ultimate failure of any articular cartilage repair as a result of the shear forces in the joint ([@b49-etm-0-0-7499]). In the present study, smoother cartilage surfaces were observed in the PRP and PRP+SC groups and the repaired cartilage of the PRP+SC group had the majority of its surface layer covered by lamina splendens. This finding suggests that the cartilage repaired in the PRP+SC group may resist longer and more adequately to heavier loads. It was speculated that this end point may be particularly important and that further histological analyses are required in cartilage repair studies.

The present study had some limitations. The follow-up period was too short to definitively understand the outcome or the lasting effects of the repaired cartilage. In addition, biomechanical evaluations to evaluate which group demonstrated better cartilage mechanical resistance to load or cartilage-derived extracellular matrix immunohistochemical staining that may further evaluate cartilage and bone quality were not used in the present cartilage repair analysis. However, full-thickness cartilage defects treated with hDPSCs in a PRP gel scaffold resulted in fewer signs of synovitis, as exhibited by reduced synovial lining cell layer thickening. In addition, enhanced histological cartilage repair was indicated to consist predominantly of hyaline-like cartilage at 12 weeks post-surgery. To conclude, the present results support the therapeutic use of hDPSCs for the treatment of full-thickness articular cartilage defects; however, further studies are warranted.
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![Surgical procedure. (A) Macroscopic view of the full-thickness defect in the trochlear groove of the femur. (B) View of PRP gel scaffold with (w) and without (wo) stem cells. (C) Macroscopic view of the defects filled with PRP gel scaffold with and without stem cells. PRP, platelet-rich plasma.](etm-17-06-4344-g00){#f1-etm-0-0-7499}

![Representative general histology of the articular cartilage defects of the experimental groups stained using hematoxylin and eosin (H&E) and Goldner trichrome (TG). In macroscopy images, scale bars=5 mm. In histological sections, scale bars=200 µm. CTL, control group without treatment; PRP, group treated with platelet-rich plasma; PRP+SC, group treated with PRP plus human dental pulp stem cells; fc, fibrocartilaginous tissue; hc, hyaline cartilage; ct, connective tissue; sb, subchondral bone.](etm-17-06-4344-g01){#f2-etm-0-0-7499}

![Representative view of synovial membrane histology from experimental groups stained using H&E. Arrows indicate the layer of synovial lining cells with some stratification in all groups at 6 weeks post-surgery. Inflammatory infiltrate was minimal and was only observed surrounding the blood vessels at 6 weeks post-surgery (arrow heads). Scale bars=100 µm. CTL, control group without treatment; PRP, group treated with platelet-rich plasma; PRP+SC, group treated with PRP plus human dental pulp stem cells.](etm-17-06-4344-g02){#f3-etm-0-0-7499}

###### 

List of antibodies used for flow cytometry.

  Antibody       Source               Supplier/cat. no.
  -------------- -------------------- --------------------------------------------------
  CD44-FITC      Mouse clone L178     BD Biosciences, San Jose, CA, USA/347943
  CD90-FITC      Mouse clone 5E10     BD Biosciences, San Jose, CA, USA/555595
  CD73-PE        Mouse clone AD2      BD Biosciences, San Jose, CA, USA/550257
  CD34-PE        Mouse clone 8G12     BD Biosciences, San Jose, CA, USA/348057
  CD45-APC       Mouse clone 2D1      BD Biosciences, San Jose, CA, USA/340942
  CD105-FITC     Mouse clone 166707   R&DSystems, Inc., Minneapolis, MN, USA/FAB10971F
  CD117-PE-CY5   Mouse clone YB5.B8   BD Biosciences, San Jose, CA, USA/559879
  CD133-PE       Mouse monoclonal     Miltenyi/120-000-425
  CD166-PE       Mouse clone 3A6      BD Biosciences, San Jose, CA, USA/559263
  CD54-PE-CY5    Mouse clone HA58     BD Biosciences, San Jose, CA, USA/555512
  STRO-1         Mouse monoclonal     R&DSystems, Inc., Minneapolis, MN, USA/MAB1038
  CD31- FITC     Mouse clone WM59     BD Biosciences, San Jose, CA, USA/555445

CD, cluster of differentiation; PE, phycoerythrin; FITC, fluorescein isothiocyanate; APC, allophycocyanin.

###### 

International Cartilage Repair Society macroscopic evaluation of cartilage repair.

  Variable                                                                                 Score
  ---------------------------------------------------------------------------------------- -------
  Degree of defect repair                                                                  
    In level with surrounding cartilage                                                    4
    75% repair of defect depth                                                             3
    50% repair of defect depth                                                             2
    25% repair of defect depth                                                             1
    0% repair of defect depth                                                              0
  Integration to border zone                                                               
    Complete integration with surrounding cartilage                                        4
    Demarcating border \<1 mm                                                              3
    3/4 of graft integrated, 1/4 with a notable border \>1 mm in width                     2
    1/2 of graft integrated with surrounding cartilage, 1/2 with a notable border \>1 mm   1
    From no contact to 1/4 of graft integrated with surrounding cartilage                  0
  Macroscopic appearance                                                                   
    Intact smooth surface                                                                  4
    Fibrillated surface                                                                    3
    Small, scattered fissures or cracks                                                    2
    Several small or few large fissures                                                    1
    Total degeneration of grafted area                                                     0
  Total overall repair assessment                                                          
    Grade I: Normal                                                                        12
    Grade II: Nearly normal                                                                8--11
    Grade III: Abnormal                                                                    4--7
    Grade IV: Severely abnormal                                                            1--3

###### 

O\'Driscoll\'s microscopic histological evaluation of articular cartilage.

  Variable                                               Score
  ------------------------------------------------------ -------
  Tissue morphology                                      
    Mostly hyaline cartilage                             4
    Mostly fibrocartilage                                3
    Mostly non-cartilage                                 2
    Exclusively non-cartilage                            1
  Matrix staining                                        
    None                                                 1
    Slight                                               2
    Moderate                                             3
    Strong                                               4
  Structural integrity                                   
    Severe disintegration                                1
    Cysts or disruption                                  2
    No organization of chondrocytes                      3
    Beginning of columnar organization of chondrocytes   4
    Normal, similar to healthy mature cartilage          5
  Chondrocyte clustering in implant                      
    25--100% of cells clustered                          1
    \<25% of cells clustered                             2
    No clusters                                          3
  Intactness of calcified layer; tidemark formation      
    \<25% of calcified layer intact                      1
    25--49% of calcified layer intact                    2
    50--75% of calcified layer intact                    3
    76--90% of calcified layer intact                    4
    Complete intactness of calcified cartilage layer     5
  Subchondral bone formation                             
    No formation                                         1
    Slight                                               2
    Strong                                               3
  Histological assessment of surface architecture        
    Severe fibrillation of disruption                    1
    Moderate fibrillation or irregularity                2
    Slight fibrillation or irregularity                  3
    Normal                                               4
  Histological assessment of defect filling              
    \<25%                                                1
    26--50%                                              2
    51--75%                                              3
    76--90%                                              4
    91--110%                                             5
  Lateral integration of implanted material              
    Not bonded                                           1
    Bonded at one hand/partially at both ends            2
    Bonded at both sides                                 3
  Basal integration of implanted material                
    \<50%                                                1
    50--70%                                              2
    70--90%                                              3
    91--100%                                             4
  Inflammation:                                          
    No inflammation                                        1
    Slight inflammation                                    3
    Strong inflammation                                    5
  Maximum total score                                    45

###### 

Krenn\'s synovitis score.

  Variable                                                                                                                     Score
  ---------------------------------------------------------------------------------------------------------------------------- ----------------------
  Enlargement of the synovial lining cell layer                                                                                
    The lining cells form one layer                                                                                            0
    The lining cells form 2--3 layers                                                                                          1
    The lining cells form 4--5 layers, few multinucleated cells might occur                                                    2
    The lining cells form \>5 layers, the lining might be ulcerated and multinucleated cells might occur                       3
  Density of the resident cells                                                                                                
    The synovial stroma shows normal cellularity                                                                               0
    The cellularity is slightly increased                                                                                      1
    The cellularity is moderately increased, multinucleated cells might occur                                                  2
    The cellularity is greatly increased, multinucleated giant cells, pannus formation and rheumatoid granulomas might occur   3
    Inflammatory infiltrate                                                                                                    
    No inflammatory infiltrate                                                                                                 0
    Few mostly perivascular situated lymphocytes or plasma cells                                                               1
    Numerous lymphocytes or plasma cells, sometimes forming follicle-like aggregates                                           2
    Dense band-like inflammatory infiltrate or numerous large follicle-like aggregates                                         3
  Total overall assessment                                                                                                     
    Sum, 0 or 1                                                                                                                No synovitis
    Sum, 2--4                                                                                                                  Low-grade synovitis
    Sum, 5--9                                                                                                                  High-grade synovitis

###### 

Macroscopic evaluation scoring.

             International cartilage repair society score mean ± standard deviation                                                                                  
  ---------- ------------------------------------------------------------------------ ----------- ----------- ------------------------------------------------------ ---------------------------------------------------------------------
  6 weeks    6.67±3.01                                                                3.60±2.37   8.86±1.35   0.0040^[a](#tfn2-etm-0-0-7499){ref-type="table-fn"}^   CTL × PRP, P=0.308
                                                                                                                                                                     CTL × PRP+SC, P=0.516
                                                                                                                                                                     ^[a](#tfn2-etm-0-0-7499){ref-type="table-fn"}^PRP × PRP+SC, P=0.003
  12 weeks   5.50±2.22                                                                7.22±1.92   9.88±0.99   0.0007^[a](#tfn2-etm-0-0-7499){ref-type="table-fn"}^   CTL × PRP, P=0.549
                                                                                                                                                                     ^[a](#tfn2-etm-0-0-7499){ref-type="table-fn"}^CTL × PRP+SC, P=0.001
                                                                                                                                                                     ^[a](#tfn2-etm-0-0-7499){ref-type="table-fn"}^PRP × PRP+SC, P=0.049

P\<0.05. CTL, control group without treatment; PRP, group treated with platelet-rich plasma; PRP + SC, group treated with platelet-rich plasma plus human dental pulp stem cells.

###### 

Histological evaluation at 6 weeks.

                                                         Mean ± standard deviation                                                                                     
  ------------------------------------------------------ --------------------------- ------------ ------------ ------------------------------------------------------- ---------------------------------------------------------------------
  Tissue morphology                                      3.83±0.41                   3.50±0.53    3.86±0.38    0.216                                                   --
  Matrix staining                                        3.83±0.41                   3.40±0.70    3.86±0.38    0.193                                                   --
  Structural integrity                                   4.0±0.00                    3.60±0.52    4.00±0.00    0.050                                                   --
  Chondrocyte clustering in implant                      2.00±0.00                   1.80±0.42    2.43±0.53    0.025^[a](#tfn3-etm-0-0-7499){ref-type="table-fn"}^     CTL × PRP, P=1,000
                                                                                                                                                                       CTL × PRP+SC, P=0.699
                                                                                                                                                                       PRP × PRP+SC, P=0.155
  Intactness of calcified layer, formation of tidemark   1.17±0.41                   1.90±1.10    1.57±0.53    0.280                                                   --
  Subchondral bone formation                             2.00±0.00                   2.40±0.52    2.29±0.49    0.222                                                   --
  Histological assessment of surface architecture        2.00±0.00                   2.50±0.53    3.86±0.38    \<0.001^[a](#tfn3-etm-0-0-7499){ref-type="table-fn"}^   CTL × PRP, P=0.675
                                                                                                                                                                       ^[a](#tfn3-etm-0-0-7499){ref-type="table-fn"}^CTL × PRP+SC, P=0.001
                                                                                                                                                                       ^[a](#tfn3-etm-0-0-7499){ref-type="table-fn"}^PRP × PRP+SC, P=0.015
  Histological assessment of defect filling              4.83±0.41                   4.50±0.53    5.00±0.00    0.065                                                   --
  Lateral integration of implanted material              2.00±0                      2.10±0.32    3.00±0       \<0.001^[a](#tfn3-etm-0-0-7499){ref-type="table-fn"}^   CTL × PRP, P=1.000
                                                                                                                                                                       ^[a](#tfn3-etm-0-0-7499){ref-type="table-fn"}^CTL × PRP+SC, P=0.007
                                                                                                                                                                       ^[a](#tfn3-etm-0-0-7499){ref-type="table-fn"}^PRP × PRP+SC, P=0.006
  Basal integration of implanted material                3.00±0                      3.50±0.53    3.43±0.79    0.156                                                   --
  Inflammation: Maximum total score                      1.00±0                      1.40±0.84    1.00±0       0.256                                                   --
  Total score                                            29.67±1.03                  30.60±4.30   34.29±1.60   0.047^[a](#tfn3-etm-0-0-7499){ref-type="table-fn"}^     CTL × PRP, P=1,000
                                                                                                                                                                       CTL × PRP+SC, P=0.062
                                                                                                                                                                       PRP × PRP+SC, P=0.164

P\<0.05. CTL, control group without treatment; PRP, group treated with platelet-rich plasma; PRP + SC, group treated with platelet-rich plasma plus human dental pulp stem cells.

###### 

Histological evaluation at 12 weeks.

                                                         Mean ± standard deviation                                                                                     
  ------------------------------------------------------ --------------------------- ------------ ------------ ------------------------------------------------------- ---------------------------------------------------------------------
  Tissue morphology                                      3.10±0.32                   3.78±0.44    4.0±0.00     0.003^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^     ^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^CTL × PRP, P=0.036
                                                                                                                                                                       ^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^CTL × PRP+SC, P=0.004
                                                                                                                                                                       PRP × PRP+SC, P=1.000
  Matrix staining                                        2.90±0.32                   3.89±0.33    3.75±0.46    0.002^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^     ^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^CTL × PRP, P=0.002
                                                                                                                                                                       ^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^CTL × PRP+SC, P=0.017
                                                                                                                                                                       PRP × PRP+SC, P=1.000
  Structural integrity                                   3.30±0.95                   4.22±0.67    4.38±0.52    0.020^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^     CTL × PRP, P=0.163
                                                                                                                                                                       CTL × PRP+SC, P=0.073
                                                                                                                                                                       PRP × PRP+SC, P=1.000
  Chondrocyte clustering in implant                      1.80±0.42                   2.00±0.50    2.63±0.52    0.007^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^     CTL × PRP, P=1.000
                                                                                                                                                                       ^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^CTL × PRP+SC, P=0.032
                                                                                                                                                                       PRP × PRP+SC, P=0.172
  Intactness of calcified layer, formation of tidemark   1.30±0.48                   2.67±1.12    2.25±0.71    0.005^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^     ^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^CTL × PRP, P=0.013
                                                                                                                                                                       CTL × PRP+SC, P=0.069
                                                                                                                                                                       PRP × PRP+SC, P=1.000
  Subchondral bone formation                             2.20±0.42                   2.89±0.33    2.88±0.35    0.002^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^     ^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^CTL × PRP, P=0.032
                                                                                                                                                                       ^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^CTL × PRP+SC, P=0.046
                                                                                                                                                                       PRP × PRP+SC, P=1.000
  Histological assessment of surface architecture        1.70±0.48                   2.89±0.78    3.38±0.52    \<0.001^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^   ^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^CTL × PRP, P=0.021
                                                                                                                                                                       ^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^CTL × PRP+SC, P=0.001
                                                                                                                                                                       PRP × PRP+SC, P=0.816
  Histological assessment of defect filling              4.80±0.42                   5.00±0.00    5.00±0.00    0.171                                                   --
  Lateral integration of implanted material              2.20±0.42                   2.22±0.44    2.50±0.53    0.335                                                   --
  Basal integration of implanted material                3.80±0.42                   3.89±0.33    3.25±0.46    0.013^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^     CTL × PRP, P=1.000
                                                                                                                                                                       CTL × PRP+SC, P=0.146
                                                                                                                                                                       PRP × PRP+SC, P=0.076
  Inflammation maximum total score                       1.00±0.00                   1.00±0.00    1.00±0.00    1.000                                                   --
  Total score                                            28.10±2.56                  34.44±3.88   35.00±2.27   0.001^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^     ^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^CTL × PRP, P=0.008
                                                                                                                                                                       ^[a](#tfn4-etm-0-0-7499){ref-type="table-fn"}^CTL × PRP+SC, P=0.002
                                                                                                                                                                       PRP × PRP+SC, P=1.000

P\<0.05. CTL, control group without treatment; PRP, group treated with platelet-rich plasma; PRP + SC, group treated with platelet-rich plasma plus human dental pulp stem cells.

###### 

Synovitis evaluation scoring.

                      Enlargement of the synovial lining cell layer   Density of the resident cells                         Inflammatory infiltrate                                            Sum of Krenn\'s synovitis score                                                                                                                             
  ---------- -------- ----------------------------------------------- ----------------------------------------------------- ------------------------------------------------------------------ --------------------------------- ------- ------------- ----------------------------------------------------- ----------------------- ------------- ------- -----
  6 weeks    CTL      1.17 (0.41)                                     0.017^[a](#tfn5-etm-0-0-7499){ref-type="table-fn"}^   ^[a](#tfn5-etm-0-0-7499){ref-type="table-fn"}^CTL × PRP, P=0.037   0.83 (0.41)                       0.622   0.83 (0.41)   0.835                                                 --                      2.83 (0.75)   0.107   Low
             PRP      0.30 (0.67)                                                                                           CTL × PRP+SC, P=0.200                                              0.90 (0.32)                               0.70 (0.48)                                                                                 1.80 (1.14)           Low
             PRP+SC   0.43 (0.53)                                                                                           PRP × PRP+SC, P=1.000                                              0.71 (0.49)                               0.71 (0.49)                                                                                 1.86 (0.90)           Low
  12 weeks   CTL      0.70 (0.48)                                     0.007^[a](#tfn5-etm-0-0-7499){ref-type="table-fn"}^   CTL × PRP, P=0.067                                                 0.20 (0.42)                       0.174   0.00 (0.00)   0.005^[a](#tfn5-etm-0-0-7499){ref-type="table-fn"}^   CTL × PRP, P=0.171      0.90 (0.74)   0.096   No
             PRP      0.10 (0.32)                                                                                           CTL × PRP+SC, P=0.120                                              0.50 (0.53)                               0.50 (0.53)                                                         CTL × PRP+SC, P=1.000   1.10 (0.99)           No
             PRP+SC   0.13 (0.35)                                                                                           PRP × PRP+SC, P=1.000                                              0.13 (0.35)                               0.00 (0.00)                                                         PRP × PRP+SC, P=0.218   0.25 (0.46)           No

P\<0.05. CTL, control group without treatment; PRP, group treated with platelet-rich plasma; PRP + SC, group treated with platelet-rich plasma plus human dental pulp stem cells; SD, standard deviation.
